Novartis reveals vital Leqvio data
The therapy involves treating individuals with atherosclerotic cardiovascular disease
Read More
Tag: Leqvio
Novartis’ cholesterol med Leqvio wins EU approval
Drug approved to help reduce cholesterol levels
Read More
- Francis Crick Institute and Medicines Discovery Catapult open applications for next KQ Labs cohort
- Novartis receives European Commission approval for Itvisma for spinal muscular atrophy
- AlzeCure enters collaboration agreement with QuantumCell ApS for NeuroRestore project
- R1 Therapeutics forms advisory board to support advancement of AP306
- UAE launches first genomics-driven clinical trial to prevent Alzheimer’s disease
